PD
KLRS

Point72 (DIFC)’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Point72 (DIFC)’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-617
Closed -$11.5K – 1554
2024
Q3 		$11.5K Sell
617
-132
-18% -$2.46K ﹤0.01% 741
2024
Q2 		$12.5K Buy
+749
New +$12.5K ﹤0.01% 747